Antivirals for influenza: where now for clinical practice and pandemic preparedness?

Lancet. 2014 Aug 2;384(9941):386-7. doi: 10.1016/S0140-6736(14)60726-1. Epub 2014 May 14.

Authors

Jonathan S Nguyen-Van-Tam¹, Peter J M Openshaw², Karl G Nicholson³

Affiliations

¹ Division of Epidemiology and Public Health, University of Nottingham, Nottingham NG5 1PB, UK. Electronic address: jvt@nottingham.ac.uk.
² National Heart and Lung Institute, Imperial College, London, UK.
³ Department of Infection, Immunity and Inflammation, University of Leicester, Leicester.

PMID: 24837882
DOI: 10.1016/S0140-6736(14)60726-1

No abstract available

MeSH terms

Antiviral Agents / therapeutic use*
Child
Humans
Influenza, Human / drug therapy*
Neuraminidase / antagonists & inhibitors*
Oseltamivir / therapeutic use
Pandemics
Zanamivir / therapeutic use

Substances

Antiviral Agents
Oseltamivir
Neuraminidase
Zanamivir

Grants and funding